Watchman Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-8,523
Closed -$1.06M 76
2021
Q2
$1.06M Sell
8,523
-1,155
-12% -$145K 0.62% 52
2021
Q1
$1.14M Sell
9,678
-187
-2% -$21.9K 0.7% 50
2020
Q4
$1.16M Sell
9,865
-530
-5% -$58.3K 0.77% 50
2020
Q3
$1.08M Buy
10,395
+390
+4% +$39.2K 0.8% 52
2020
Q2
$917K Sell
10,005
-780
-7% -$74.8K 0.76% 51
2020
Q1
$973K Sell
10,785
-430
-4% -$45.7K 1% 44
2019
Q4
$1.27M Buy
+11,215
New +$1.23M 0.95% 45

Other funds holding MDT

Watchman Group's MDT Position: Q3 2021 in Review

Watchman Group sold out of Medtronic (MDT) in Q3 2021, closing a stake of 8,523 shares — an estimated $1.06M sold.

Watchman Group first reported a position in MDT in Q4 2019 and held it in 7 quarters. The position peaked at $1.27M in Q4 2019. 2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

  • Watchman Group reported no remaining Medtronic position as of Q3 2021 after selling out during the quarter.
  • Watchman Group sold 8,523 Medtronic shares in Q3 2021, an estimated $1.06M.
  • Watchman Group first reported a position in Medtronic in Q4 2019 and held it in 7 quarters.
  • Watchman Group's Medtronic position peaked at $1.27M in Q4 2019.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Watchman Group's 13F filing for Q3 2021, filed 9 Nov 2021.